Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

MicroRNAs within the continuum of postgenomics biomarker discovery.

Mayr M, Zampetaki A, Willeit P, Willeit J, Kiechl S.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):206-14. doi: 10.1161/ATVBAHA.112.300141. Review.

2.

Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.

Smith JG, Gerszten RE.

Circulation. 2017 Apr 25;135(17):1651-1664. doi: 10.1161/CIRCULATIONAHA.116.025446. Review.

PMID:
28438806
3.

Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.

Herder C, Karakas M, Koenig W.

Clin Pharmacol Ther. 2011 Jul;90(1):52-66. doi: 10.1038/clpt.2011.93. Epub 2011 Jun 8. Review.

PMID:
21654741
4.

Novel methodologies for biomarker discovery in atherosclerosis.

Hoefer IE, Steffens S, Ala-Korpela M, Bäck M, Badimon L, Bochaton-Piallat ML, Boulanger CM, Caligiuri G, Dimmeler S, Egido J, Evans PC, Guzik T, Kwak BR, Landmesser U, Mayr M, Monaco C, Pasterkamp G, Tuñón J, Weber C; ESC Working Group Atherosclerosis and Vascular Biology.

Eur Heart J. 2015 Oct 14;36(39):2635-42. doi: 10.1093/eurheartj/ehv236. Epub 2015 Jun 5. Review.

PMID:
26049157
5.

MicroRNAs in cardiovascular diseases: biology and potential clinical applications.

Kartha RV, Subramanian S.

J Cardiovasc Transl Res. 2010 Jun;3(3):256-70. doi: 10.1007/s12265-010-9172-z. Epub 2010 Feb 25. Review.

PMID:
20560047
6.

Early identification of cardiovascular risk using genomics and proteomics.

Kullo IJ, Cooper LT.

Nat Rev Cardiol. 2010 Jun;7(6):309-17. doi: 10.1038/nrcardio.2010.53. Epub 2010 May 4. Review.

7.

Precision Medicine, Cardiovascular Disease and Hunting Elephants.

Joyner MJ.

Prog Cardiovasc Dis. 2016 May-Jun;58(6):651-60. doi: 10.1016/j.pcad.2016.02.004. Epub 2016 Feb 21. Review.

PMID:
26902518
8.

Regulatory RNAs and cardiovascular disease - with a special focus on circulating microRNAs.

Dlouhá D, Hubáček JA.

Physiol Res. 2017 Apr 5;66(Supplementum 1):S21-S38. Review.

9.

Transcriptomic biomarkers of cardiovascular disease.

Pedrotty DM, Morley MP, Cappola TP.

Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):64-9. doi: 10.1016/j.pcad.2012.06.003. Review.

10.

Clinical validation of genetic markers for improved risk estimation.

Kessler T, Schunkert H.

Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):25-32. doi: 10.1177/2047487312448993. Review.

PMID:
22801067
11.

Dissecting the roles of microRNAs in coronary heart disease via integrative genomic analyses.

Huan T, Rong J, Tanriverdi K, Meng Q, Bhattacharya A, McManus DD, Joehanes R, Assimes TL, McPherson R, Samani NJ, Erdmann J, Schunkert H, Courchesne P, Munson PJ, Johnson AD, O'Donnell CJ, Zhang B, Larson MG, Freedman JE, Levy D, Yang X.

Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):1011-21. doi: 10.1161/ATVBAHA.114.305176. Epub 2015 Feb 5.

12.

Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.

Sookoian S, Pirola CJ.

World J Gastroenterol. 2015 Jan 21;21(3):711-25. doi: 10.3748/wjg.v21.i3.711. Review.

13.

Circulating microRNAs: understanding the limits for quantitative measurement by real-time PCR.

Hardikar AA, Farr RJ, Joglekar MV.

J Am Heart Assoc. 2014 Feb 26;3(1):e000792. doi: 10.1161/JAHA.113.000792. No abstract available.

14.

Exploring predisposition and treatment response--the promise of genomics.

Pan S, Knowles JW.

Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):56-63. doi: 10.1016/j.pcad.2012.04.006. Review.

15.

Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.

Kondkar AA, Abu-Amero KK.

Biomed Res Int. 2015;2015:821823. doi: 10.1155/2015/821823. Epub 2015 Feb 1. Review.

16.

Multiparametric Imaging of Organ System Interfaces.

Vandoorne K, Nahrendorf M.

Circ Cardiovasc Imaging. 2017 Apr;10(4). pii: e005613. doi: 10.1161/CIRCIMAGING.116.005613. Review.

PMID:
28360260
18.

A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience.

Kraus WE, Granger CB, Sketch MH Jr, Donahue MP, Ginsburg GS, Hauser ER, Haynes C, Newby LK, Hurdle M, Dowdy ZE, Shah SH.

J Cardiovasc Transl Res. 2015 Nov;8(8):449-57. doi: 10.1007/s12265-015-9648-y. Epub 2015 Aug 14. Review.

19.

The emerging role of microRNAs in cardiovascular disease.

Maegdefessel L.

J Intern Med. 2014 Dec;276(6):633-44. doi: 10.1111/joim.12298. Epub 2014 Sep 23. Review.

20.

Biomarkers of cardiovascular disease: molecular basis and practical considerations.

Vasan RS.

Circulation. 2006 May 16;113(19):2335-62. Review. No abstract available.

Supplemental Content

Support Center